机构:[1]Sichuan Univ, W China Hosp, Stroke Clin Res Unit, Dept Neurol, Chengdu 610041, Peoples R China;[2]Beijing Neurosurg Inst, Dept Neuroepidemiol, Beijing, Peoples R China;研究所北京市神经外科研究所首都医科大学附属天坛医院[3]Peking Univ, Hlth Sci Ctr, Dept Epidemiol & Biostat, Sch Publ Hlth, Beijing 100871, Peoples R China;[4]Sichuan Univ, W China Hosp, Stroke Clin Res Unit, Dept Neurol, Chengdu 610041, Peoples R China;[5]Bur Dis Prevent & Control, Minist Hlth, Beijing, Peoples R China
In this review, we examine the current status of stroke epidemiology, prevention, and management strategies in mainland China. The main findings suggested that total age-adjusted incidence of first-ever stroke in China is not very different from that in developed countries. Stroke incidence, mortality, and prevalence varied widely among different regions within China, with a noticeable north-south gradient. The proportion of intracerebral haemorrhage was high and reached 55% in one city. Hypertension is the most important risk factor for stroke. The mass approach combined with a high-risk approach for stroke prevention showed encouraging effects, and various unconventional local therapeutic traditions are commonly used to treat stroke in China. Several national guidelines on stroke prevention and treatment have been developed. Because of methodological limitations in the epidemiology studies, data are unreliable in terms of making any firm conclusions. Up-to-date, well-designed, and well-done epidemiological studies and therapeutic trials in China are urgently needed.
第一作者机构:[1]Sichuan Univ, W China Hosp, Stroke Clin Res Unit, Dept Neurol, Chengdu 610041, Peoples R China;[2]Beijing Neurosurg Inst, Dept Neuroepidemiol, Beijing, Peoples R China;[3]Peking Univ, Hlth Sci Ctr, Dept Epidemiol & Biostat, Sch Publ Hlth, Beijing 100871, Peoples R China;[4]Sichuan Univ, W China Hosp, Stroke Clin Res Unit, Dept Neurol, Chengdu 610041, Peoples R China;[5]Bur Dis Prevent & Control, Minist Hlth, Beijing, Peoples R China
通讯作者:
通讯机构:[1]Sichuan Univ, W China Hosp, Stroke Clin Res Unit, Dept Neurol, Chengdu 610041, Peoples R China;[2]Beijing Neurosurg Inst, Dept Neuroepidemiol, Beijing, Peoples R China;[3]Peking Univ, Hlth Sci Ctr, Dept Epidemiol & Biostat, Sch Publ Hlth, Beijing 100871, Peoples R China;[4]Sichuan Univ, W China Hosp, Stroke Clin Res Unit, Dept Neurol, Chengdu 610041, Peoples R China;[5]Bur Dis Prevent & Control, Minist Hlth, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Liu Ming,Wu Bo,Wang Wen-Zhi,et al.Stroke in China: epidemiology, prevention, and management strategies[J].LANCET NEUROLOGY.2007,6(5):456-464.doi:10.1016/S1474-4422(07)70004-2.
APA:
Liu, Ming,Wu, Bo,Wang, Wen-Zhi,Lee, Li-Ming,Zhang, Shi-Hong&Kong, Ling-Zhi.(2007).Stroke in China: epidemiology, prevention, and management strategies.LANCET NEUROLOGY,6,(5)
MLA:
Liu, Ming,et al."Stroke in China: epidemiology, prevention, and management strategies".LANCET NEUROLOGY 6..5(2007):456-464